128 results
8-K
EX-99.1
PTCT
PTC Therapeutics Inc
25 Apr 24
Results of Operations and Financial Condition
4:10pm
to $195.1 million for the first quarter of 2023. The decrease in research and development expenses reflects strategic portfolio prioritization … and development reconciliation
GAAP research and development
Less: share-based compensation expense
Non-GAAP research and development
(2) Selling, general
8-K
EX-99.1
e5mpb1e 7bt
29 Feb 24
Results of Operations and Financial Condition
4:15pm
8-K
EX-99.1
pyw2s6k
8 Jan 24
Results of Operations and Financial Condition
9:27am
8-K
EX-99.1
wjrklr outwyti95xb8
26 Oct 23
Results of Operations and Financial Condition
4:07pm
8-K
EX-10.1
mf1s9
22 Sep 23
Other Events
9:00am
8-K
EX-99.1
omnueqj99rkzr69wown1
3 Aug 23
Results of Operations and Financial Condition
4:03pm
8-K
EX-10.1
hhsdqpa
17 Jul 23
Departure of Directors or Certain Officers
4:46pm
S-3ASR
475 tywwv28
5 May 23
Automatic shelf registration
4:31pm
8-K
EX-99.1
639hc xe6u
27 Apr 23
Results of Operations and Financial Condition
4:02pm
8-K
EX-10.1
teb0dad7592aq6 13rzq
18 Apr 23
Departure of Directors or Certain Officers
5:11pm